Both will validate the clinical performance of two new diagnostic tests for regulatory submission
News
Alliance Healthcare launches cancer symptom referral scheme in UK pharmacies
Macmillan Cancer Support estimated that around three million people in the UK were living with cancer in 2022
Unitaid funds over £6m to Liverpool researchers to treat major diseases
The project aims to advance therapeutics for tuberculosis, malaria and hepatitis C in LMICs
Key mechanism controlling bone marrow stem cells could lead to new therapies
Hoxa9 and b-catenin molecules are a rare population of self-renewing HSCs found in bone marrow
myTomorrows and brainstrust partner to support patients living with brain cancer
Affecting 80,000 people in England, 12% of brain tumour patients survive beyond five years of diagnosis
KCL project receives £100,000 UK government funding to boost AI-assisted healthcare
The project will assist researchers and companies in training the technology for healthcare settings
Study reveals new aptamer targeting tool can detect early signs of motor neurone disease
The fatal, progressive neurological condition currently affects around 5,000 people in the UK
Study reveals new liquid biopsy test could benefit thousands of lung cancer patients
The third most common and serious form of cancer affects over 43,000 people every year in the UK
Researchers suggest form of Alzheimer’s is transmissible via bone marrow transplants
The progressive neurodegenerative disease is estimated to affect 24 million people globally
Collaborators form national NHS patient database registry for Lynch syndrome patients
The genetic condition affects one in 279 people in England and significantly increases cancer risk
Researchers reveal people with Parkinson’s more likely to experience delirium in hospital
Two out of three people with the neurodegenerative condition experienced delirium in hospital
Strand Therapeutics develops new class of mRNA molecules for cancer
The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases
University of Liverpool to lead £125m research facility supported by UKRI investment
Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m
PMLiVE’s T40 – open for submissions!
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
LifeArc provides £750,000 fund for clinical trial to treat neuroferritinopathy
The progressive and incurable brain disorder currently affects approximately 100 patients worldwide
